Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  McKesson Corporation    MCK

MCKESSON CORPORATION (MCK)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

McKesson Corporation : McKesson and Epic Settle Patent Infringement Litigation

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/04/2013 | 08:11pm CET


Settlement allows companies to focus on needs of customers

SAN FRANCISCO, March 4, 2013 - McKesson Corporation and Epic Systems Corporation have settled their longstanding patent infringement litigation involving McKesson's U.S. patent #6,757,898 and Epic's MyChart software. 

Under terms of the settlement, McKesson agreed to grant Epic a license to the patent for the benefit of Epic and its customers.  In exchange, Epic agreed that it will no longer contest the validity of the patent, allowing McKesson and Epic to return to normalcy in their relationship going forward.  The parties also agreed to dismiss all pending claims and counterclaims and end any further litigation and appeals.

Executives from both parties recognized the settlement as one that will benefit the healthcare industry in general, and allow both parties to focus on the needs of their customers. 

"We're delighted to have settled this litigation with McKesson," said Carl Dvorak, chief operating officer, Epic Systems Corporation.

"We look forward to reestablishing our prior relationship and exploring new opportunities to serve our mutual customers," echoed Jeff Felton, president of McKesson's RelayHealth business. "Both companies will benefit by putting this litigation behind us."

About McKesson Corporation

McKesson Corporation, currently ranked 14th on the FORTUNE 500, is a healthcare services and information technology company dedicated to making the business of healthcare run better. We partner with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care to build healthier organizations that deliver better care to patients in every setting. McKesson helps its customers improve their financial, operational, and clinical performance with solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services.www.mckesson.com.

PR Contact

Kris Fortner
415.983.8352
kris.fortner@mckesson.com



distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MCKESSON CORPORATION
11/15 Bayer hires new blood to stem 'Amazon effect' in consumer health
11/13 MCKESSON : Real-World Evidence from Electronic Health Record Data
11/10 MCKESSON : Human Rights Campaign Honors McKesson As Best Place to Work for Fifth..
11/06 MCKESSON : Strengthens Its Portfolio of Manufacturer Solutions with the Acquisit..
11/02 NRG ENERGY : McKesson Partners with NRG to Install Solar Arrays at McKesson Faci..
11/02 MCKESSON : Recommends Quick Federal Action on Key Opioid Solution Ideas
10/31 MCKESSON : CADCA, McKesson Launch Pilot Program Addressing Veteran Substance Abu..
10/31 MCKESSON : Recommends Quick Federal Action on Key Opioid Solution Ideas
10/30 MCKESSON : The Business of Health Care October 2017
10/30 MCKESSON : Signs Agreement with NRG to Install Solar Arrays at McKesson Facility
More news
News from SeekingAlpha
09:10a 7 Black Friday Sales You'll Be Thankful For In 2018
11/23 Tracking Larry Robbins' Glenview Capital Management Portfolio - Q3 2017 Updat..
11/22 102 Dividend Growth Stocks Going Ex-Dividend Next Week
11/20 Cost of U.S. opioid epidemic tops $500B
11/17 Thursday Was About Wal-Mart And Cisco - Cramer's Mad Money (11/16/17)
Financials ($)
Sales 2018 205 B
EBIT 2018 3 621 M
Net income 2018 1 815 M
Debt 2018 3 172 M
Yield 2018 0,82%
P/E ratio 2018 21,45
P/E ratio 2019 15,19
EV / Sales 2018 0,16x
EV / Sales 2019 0,16x
Capitalization 30 396 M
Chart MCKESSON CORPORATION
Duration : Period :
McKesson Corporation Technical Analysis Chart | MCK | US58155Q1031 | 4-Traders
Technical analysis trends MCKESSON CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 14
Average target price 169 $
Spread / Average Target 16%
EPS Revisions
Managers
NameTitle
John H. Hammergren Chairman, President & Chief Executive Officer
James A. Beer Chief Financial Officer & Executive Vice President
Kathleen D. McElligott Chief Technology & Information Officer, EVP
M. Christine Jacobs Independent Director
Marie L. Knowles Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MCKESSON CORPORATION3.81%30 396
CVS HEALTH-9.42%72 409
WALGREENS BOOTS ALLIANCE-13.81%72 011
EXPRESS SCRIPTS HOLDING CO-9.70%35 183
CARDINAL HEALTH INC-20.84%17 958
AMERISOURCEBERGEN CORP.4.11%17 752